Search hospitals > Wisconsin > Sturgeon Bay
Green Bay Oncology - Sturgeon Bay
Claim this profileSturgeon Bay, Wisconsin 54235
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
217 reported clinical trials
3 medical researchers
Summary
Green Bay Oncology - Sturgeon Bay is a medical facility located in Sturgeon Bay, Wisconsin. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Green Bay Oncology - Sturgeon Bay is involved with conducting 217 clinical trials across 277 conditions. There are 3 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, and Anthony J. Jaslowski.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage III
Stage IV
Stage II
Top PIs
Matthew L. RyanSaint Vincent Hospital Cancer Center Green Bay1 year of reported clinical research
Expert in Cancer
Studies Recurrence
47 reported clinical trials
114 drugs studied
Brian L. BurnetteSaint Vincent Hospital Cancer Center Green Bay4 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
30 reported clinical trials
82 drugs studied
Anthony J. JaslowskiSaint Vincent Hospital Cancer Center Green Bay5 years of reported clinical research
Expert in Cancer
Studies Breast Cancer
23 reported clinical trials
42 drugs studied
Clinical Trials running at Green Bay Oncology - Sturgeon Bay
Non-Small Cell Lung Cancer
Lung Cancer
ALK Gene Rearrangement
Cancer
Colorectal Cancer
Adenoma
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Green Bay Oncology - Sturgeon Bay?
Green Bay Oncology - Sturgeon Bay is a medical facility located in Sturgeon Bay, Wisconsin. This center is recognized for care of Breast Cancer, Cancer, Lung Cancer, Recurrence, Non-Small Cell Lung Cancer and other specialties. Green Bay Oncology - Sturgeon Bay is involved with conducting 217 clinical trials across 277 conditions. There are 3 research doctors associated with this hospital, such as Matthew L. Ryan, Brian L. Burnette, and Anthony J. Jaslowski.